Clinicians Globally Have Used Mallinckrodt's Unique and Highly Specialized Extracorporeal Photopheresis (ECP) System to Deliver More than 1 Million Patient Treatments Globally STAINES-UPON-THAMES, England, May 3, 2017 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading...
Read More